Qardioarm blood pressure monitoring in a population with type 2 diabetes: Validation study

2Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Home blood pressure monitoring has many benefits, even more so, in populations prone to high blood pressure, such as persons with diabetes. Objective: The purpose of this research was to validate the QardioArm mobile device in a sample of individuals with noninsulin-dependent type 2 diabetes in accordance with the guidelines of the second International Protocol of the European Society of Hypertension. Methods: The sample consisted of 33 patients with type 2 diabetes. To evaluate the validity of QardioArm by comparing its data with that obtained with a digital sphygmomanometer (Omron M3 Intellisense), two nurses collected diastolic blood pressure, systolic blood pressure, and heart rate with both devices. Results: The analysis indicated that the test device QardioArm met all the validation requirements using a sample population with type 2 diabetes. Conclusions: This paper reports the first validation of QardioArm in a population of individuals with noninsulin-dependent type 2 diabetes. QardioArm for home monitoring of blood pressure and heart rate met the requirements of the second International Protocol of the European Society of Hypertension.

Cite

CITATION STYLE

APA

Mazoteras-Pardo, V., Becerro-De-Bengoa-Vallejo, R., Losa-Iglesias, M. E., Martínez-Jiménez, E. M., Calvo-Lobo, C., Romero-Morales, C., … Palomo-López, P. (2020). Qardioarm blood pressure monitoring in a population with type 2 diabetes: Validation study. Journal of Medical Internet Research, 22(7). https://doi.org/10.2196/19781

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free